CSL Limited Stock Rating Reaffirmed by CIMB (CSL)
CSL Limited (ASX:CSL)‘s stock had its “neutral” rating restated by equities research analysts at CIMB in a research note issued to investors on Wednesday, Analyst Ratings.Net reports.
Shares of CSL Limited (ASX:CSL) traded down 0.49% on Wednesday, hitting A$64.880. 257,324 shares of the company’s stock traded hands. CSL Limited has a 1-year low of A$38.320 and a 1-year high of A$64.700. The stock has a 50-day moving average of A$59.93 and a 200-day moving average of A$58.04. The company has a market cap of A$31.619 billion and a price-to-earnings ratio of 26.82.
Other equities research analysts have also recently issued reports about the stock. Analysts at Deutsche Bank reiterated a “hold” rating on shares of CSL Limited in a research note to investors on Wednesday, September 25th.
CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.